Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05836103 · ClinicalTrials.gov registry record · NA

Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation

A NA study of Tobacco Cigarette Smoking, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT05836103 is a NA study of Tobacco Cigarette Smoking that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05836103, a NA study of Tobacco Cigarette Smoking, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (ACT) offer a different approach, which teaches smokers psychological flexibility through accepting negative experiences. While there is evidence for the efficacy of both CBT and Mindfulness/ACT smoking cessation interventions, it is unclear if these approaches are efficacious when implemented in real-time and with young adults. The overall goal of this proposal is to evaluate the efficacy of CBT and Mindfulness/ACT messages for young adults targeted at specific high-risk situations for smoking.

Conditions Studied

Interventions

  • BEHAVIORAL Smartphone-based intervention messages

Study Locations (1)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2024-10-22
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT05836103

The ClinicalTrials.gov registry entry for NCT05836103 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Cigarette Smoking appearing as the primary indexed condition, and to 1 intervention - of which Smartphone-based intervention messages is the first listed.

NCT05836103 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05836103 about?

NCT05836103 is a clinical study titled "Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation". Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (ACT) offer a different approach, which teaches smokers psychological flexibility through accepting n...

What is the current status of trial NCT05836103?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-10-22. Estimated completion is 2026-06-30.

What conditions does trial NCT05836103 study?

This clinical trial studies the following conditions: Tobacco Cigarette Smoking.

What interventions are being tested in trial NCT05836103?

The interventions under investigation include: Smartphone-based intervention messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT05836103?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05836103 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.